Study design
RECRUITMENT
This was an investigator-initiated, single-center, randomized, patient-blinded trial with a two-arm, parallel design. The Institutional Review Board of Samsung Medical Center approved this study (no. SMC 2021-04-124, approval date: 21/05/2021). This study was registered with the Clinical Trial Registry of Korea prior to the recruitment of the first participant (